Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 3:20 PM EDT

Compugen (CGEN) Share-based Compensation Growth (3y) (2020 - 2021)

Analysis

Compugen (CGEN) Share-based Compensation Growth (3y) (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn 12.91%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 6.35%
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn 17.49%
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 9.95%
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 4.55%
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 30.98%
10 Compugen 241.50 Mn 155.89 Mn -92,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 13.29%
Jun 30, 2021 25.32%
Dec 31, 2020 -11.67%